Literature DB >> 18598747

Running on empty: how p53 controls INS/IGF signaling and affects life span.

Heidi Scrable1, Silvia Medrano, Erica Ungewitter.   

Abstract

In higher organisms dependent on the regenerative ability of tissue stem cells to maintain tissue integrity throughout adulthood, the failure of stem cells to replace worn out, dead, or damaged cells is seen as one mechanism that limits life span. In these organisms, tumor suppressors such as p53 are central participants in the control of longevity because they regulate stem cell proliferation. Several recent reports have identified p53 as a longevity gene in organisms such as Caenorhabditis elegans and Drosophila melanogaster, which lack proliferative stem cells in all but the germline and have relatively short life spans. This has forced us to reevaluate the role of p53 in the control of life span. We discuss how p53 might regulate longevity in both long- and short-lived species by controlling the activity of insulin-like molecules that operate in proliferating and non-proliferating compartments of adult somatic tissues. We also discuss the hierarchical structure of life span regulation where loss of p53 has life span extending effects. Finally, we suggest a molecular mechanism by which p53 might facilitate the response to severe nutrient deprivation that allows metabolically active cells to survive periods of starvation. Paradoxically, loss of p53 function in these cells would compromise life span.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18598747      PMCID: PMC2764313          DOI: 10.1016/j.exger.2008.05.017

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  92 in total

Review 1.  Molecular interactions of the IGF system.

Authors:  Adam Denley; Leah J Cosgrove; Grant W Booker; John C Wallace; Briony E Forbes
Journal:  Cytokine Growth Factor Rev       Date:  2005 Aug-Oct       Impact factor: 7.638

2.  Reduced insulin/IGF-1 signalling and human longevity.

Authors:  Diana van Heemst; Marian Beekman; Simon P Mooijaart; Bastiaan T Heijmans; Bernd W Brandt; Bas J Zwaan; P Eline Slagboom; Rudi G J Westendorp
Journal:  Aging Cell       Date:  2005-04       Impact factor: 9.304

3.  p53 isoforms can regulate p53 transcriptional activity.

Authors:  Jean-Christophe Bourdon; Kenneth Fernandes; Fiona Murray-Zmijewski; Geng Liu; Alexandra Diot; Dimitris P Xirodimas; Mark K Saville; David P Lane
Journal:  Genes Dev       Date:  2005-08-30       Impact factor: 11.361

4.  The coordinate regulation of the p53 and mTOR pathways in cells.

Authors:  Zhaohui Feng; Haiyan Zhang; Arnold J Levine; Shengkan Jin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-31       Impact factor: 11.205

5.  Increased neurogenesis in dentate gyrus of long-lived Ames dwarf mice.

Authors:  Liou Y Sun; M Steven Evans; Jenny Hsieh; Jacob Panici; Andrzej Bartke
Journal:  Endocrinology       Date:  2004-11-24       Impact factor: 4.736

Review 6.  Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle.

Authors:  Thea Shavlakadze; Nadine Winn; Nadia Rosenthal; Miranda D Grounds
Journal:  Growth Horm IGF Res       Date:  2005-01-21       Impact factor: 2.372

Review 7.  DeltaNp53 or p44: priming the p53 pump.

Authors:  Heidi Scrable; Tsutomu Sasaki; Bernhard Maier
Journal:  Int J Biochem Cell Biol       Date:  2005-01-11       Impact factor: 5.085

8.  The ELAV RNA-stability factor HuR binds the 5'-untranslated region of the human IGF-IR transcript and differentially represses cap-dependent and IRES-mediated translation.

Authors:  Zheng Meng; Peter H King; L Burt Nabors; Nateka L Jackson; Ching-Yi Chen; Peter D Emanuel; Scott W Blume
Journal:  Nucleic Acids Res       Date:  2005-05-24       Impact factor: 16.971

Review 9.  Role of insulin-like growth factor 1 receptor signalling in cancer.

Authors:  O Larsson; A Girnita; L Girnita
Journal:  Br J Cancer       Date:  2005-06-20       Impact factor: 7.640

10.  Longer lifespan, altered metabolism, and stress resistance in Drosophila from ablation of cells making insulin-like ligands.

Authors:  Susan J Broughton; Matthew D W Piper; Tomoatsu Ikeya; Timothy M Bass; Jake Jacobson; Yasmine Driege; Pedro Martinez; Ernst Hafen; Dominic J Withers; Sally J Leevers; Linda Partridge
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-11       Impact factor: 11.205

View more
  8 in total

Review 1.  The origins and evolution of the p53 family of genes.

Authors:  Vladimir A Belyi; Prashanth Ak; Elke Markert; Haijian Wang; Wenwei Hu; Anna Puzio-Kuter; Arnold J Levine
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-16       Impact factor: 10.005

2.  The p53 family: guardians of maternal reproduction.

Authors:  Arnold J Levine; Richard Tomasini; Frank D McKeon; Tak W Mak; Gerry Melino
Journal:  Nat Rev Mol Cell Biol       Date:  2011-04       Impact factor: 94.444

3.  Chronic hypoxia impairs muscle function in the Drosophila model of Duchenne's muscular dystrophy (DMD).

Authors:  Matias Mosqueira; Gabriel Willmann; Hannele Ruohola-Baker; Tejvir S Khurana
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

Review 4.  Calorie restriction and cancer prevention: metabolic and molecular mechanisms.

Authors:  Valter D Longo; Luigi Fontana
Journal:  Trends Pharmacol Sci       Date:  2010-01-25       Impact factor: 14.819

5.  Drosophila foxo acts in males to cause sexual-dimorphism in tissue-specific p53 life span effects.

Authors:  Jie Shen; John Tower
Journal:  Exp Gerontol       Date:  2009-10-17       Impact factor: 4.032

6.  Premature cardiac senescence in DahlS.Z-Lepr(fa)/Lepr(fa) rats as a new animal model of metabolic syndrome.

Authors:  Keiji Takahashi; Miwa Takatsu; Takuya Hattori; Tamayo Murase; Sae Ohura; Yuuri Takeshita; Shogo Watanabe; Toyoaki Murohara; Kohzo Nagata
Journal:  Nagoya J Med Sci       Date:  2014-02       Impact factor: 1.131

7.  p53 is required for brain growth but is dispensable for resistance to nutrient restriction during Drosophila larval development.

Authors:  Esteban G Contreras; Jimena Sierralta; Alvaro Glavic
Journal:  PLoS One       Date:  2018-04-05       Impact factor: 3.240

8.  Increased Plin2 expression in human skeletal muscle is associated with sarcopenia and muscle weakness.

Authors:  Maria Conte; Francesco Vasuri; Giovanni Trisolino; Elena Bellavista; Aurelia Santoro; Alessio Degiovanni; Ermanno Martucci; Antonia D'Errico-Grigioni; Daniela Caporossi; Miriam Capri; Andrea B Maier; Olivier Seynnes; Laura Barberi; Antonio Musarò; Marco V Narici; Claudio Franceschi; Stefano Salvioli
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.